These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 30664219)
1. Identification of differentially expressed genes and enriched pathways in lung cancer using bioinformatics analysis. Long T; Liu Z; Zhou X; Yu S; Tian H; Bao Y Mol Med Rep; 2019 Mar; 19(3):2029-2040. PubMed ID: 30664219 [TBL] [Abstract][Full Text] [Related]
2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
3. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis. Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743 [TBL] [Abstract][Full Text] [Related]
4. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma. Zhou LN; Li SC; Li XY; Ge H; Li HM Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
6. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis. Li F; Guo P; Dong K; Guo P; Wang H; Lv X J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342 [No Abstract] [Full Text] [Related]
7. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis. Hu S; Liao Y; Chen L Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925 [TBL] [Abstract][Full Text] [Related]
8. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer. Wang Y; Zhang Y; Huang Q; Li C Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125 [TBL] [Abstract][Full Text] [Related]
9. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis. Yu C; Chen F; Jiang J; Zhang H; Zhou M Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250 [TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis to identify key genes and pathways influencing synovial inflammation in osteoarthritis. Lin J; Wu G; Zhao Z; Huang Y; Chen J; Fu C; Ye J; Liu X Mol Med Rep; 2018 Dec; 18(6):5594-5602. PubMed ID: 30365099 [TBL] [Abstract][Full Text] [Related]
11. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618 [TBL] [Abstract][Full Text] [Related]
12. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis. Xu Z; Jiang P; He S Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546 [TBL] [Abstract][Full Text] [Related]
13. Differentially Expressed Gene Screening, Biological Function Enrichment, and Correlation with Prognosis in Non-Small Cell Lung Cancer. Huang H; Huang Q; Tang T; Zhou X; Gu L; Lu X; Liu F Med Sci Monit; 2019 Jun; 25():4333-4341. PubMed ID: 31181055 [TBL] [Abstract][Full Text] [Related]
14. Identification of potential therapeutic targets for lung cancer by bioinformatics analysis. Wang LQ; Zhao LH; Qiao YZ Mol Med Rep; 2016 Mar; 13(3):1975-82. PubMed ID: 26739332 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA‑gene pairs in small‑cell lung cancer. Mao Y; Xue P; Li L; Xu P; Cai Y; Chu X; Jiang P; Zhu S Mol Med Rep; 2019 Sep; 20(3):2199-2208. PubMed ID: 31257520 [TBL] [Abstract][Full Text] [Related]
16. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer. Liu X; Liu X; Li J; Ren F Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030 [TBL] [Abstract][Full Text] [Related]
17. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis. Zhang H; Liu J; Fu X; Yang A Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723 [TBL] [Abstract][Full Text] [Related]
18. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker. Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z Gene; 2019 May; 698():9-18. PubMed ID: 30825595 [TBL] [Abstract][Full Text] [Related]
19. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments. Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343 [TBL] [Abstract][Full Text] [Related]
20. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer. Baruah MM; Sharma N Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]